|
1
|
Mirabello L, Troisi RJ and Savage SA:
Osteosarcoma incidence and survival rates from 1973 to 2004: Data
from the surveillance, epidemiology, and end results program.
Cancer. 115:1531–1543. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Rytting M, Pearson P, Raymond AK, Ayala A,
Murray J, Yasko AW, Johnson M and Jaffe N: Osteosarcoma in
preadolescent patients. Clin Orthop Relat Res. 373:39–50. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ferguson WS and Goorin AM: Current
treatment of osteosarcoma. Cancer Invest. 19:292–315. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yang J and Zhang W: New molecular insights
into osteosarcoma targeted therapy. Curr Opin Oncol. 25:398–406.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Fabian MR, Sonenberg N and Filipowicz W:
Regulation of mRNA translation and stability by microRNAs. Annu Rev
Biochem. 79:351–379. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Guo H, Ingolia NT, Weissman JS and Bartel
DP: Mammalian microRNAs predominantly act to decrease target mRNA
levels. Nature. 466:835–840. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lu J, Getz G, Miska EA, Alvarez-Saavedra
E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA,
et al: MicroRNA expression profiles classify human cancers. Nature.
435:834–838. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
McManus MT: MicroRNAs and cancer. Semin
Cancer Biol. 13:253–258. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Calin GA and Croce CM: MicroRNA-cancer
connection: The beginning of a new tale. Cancer Res. 66:7390–7394.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yan K, Gao J, Yang T, Ma Q, Qiu X, Fan Q
and Ma B: MicroRNA-34a inhibits the proliferation and metastasis of
osteosarcoma cells both in vitro and in vivo. PLoS One.
7:e337782012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Liu LH, Li H, Li JP, Zhong H, Zhang HC,
Chen J and Xiao T: miR-125b suppresses the proliferation and
migration of osteosarcoma cells through down-regulation of STAT3.
Biochem Biophys Res Commun. 416:31–38. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang H, Cai X, Wang Y, Tang H, Tong D and
Ji F: MicroRNA-143, downregulated in osteosarcoma, promotes
apoptosis and suppresses tumorigenicity by targeting Bcl-2. Oncol
Rep. 24:1363–1369. 2010.PubMed/NCBI
|
|
13
|
Ziyan W, Shuhua Y, Xiufang W and Xiaoyun
L: MicroRNA-21 is involved in osteosarcoma cell invasion and
migration. Med Oncol. 28:1469–1474. 2011. View Article : Google Scholar
|
|
14
|
Wei R, Deng Z and Su J: miR-217 targeting
Wnt5a in osteosarcoma functions as a potential tumor suppressor.
Biomed Pharmacother. 72:158–164. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chong Y, Zhang J, Guo X, Li G, Zhang S, Li
C, Jiao Z and Shao M: MicroRNA-503 acts as a tumor suppressor in
osteosarcoma by targeting L1CAM. PLoS One. 9:e1145852014.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lin SP, Youngson N, Takada S, Seitz H,
Reik W, Paulsen M, Cavaille J and Ferguson-Smith AC: Asymmetric
regulation of imprinting on the maternal and paternal chromosomes
at the Dlk1-Gtl2 imprinted cluster on mouse chromosome 12. Nat
Genet. 35:97–102. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang W, Peng B, Wang D, Ma X, Jiang D,
Zhao J and Yu L: Human tumor microRNA signatures derived from
large-scale oligonucleotide microarray datasets. Int J Cancer.
129:1624–1634. 2011. View Article : Google Scholar
|
|
18
|
Miranda PJ, Vimalraj S and Selvamurugan N:
A feedback expression of microRNA-590 and activating transcription
factor-3 in human breast cancer cells. Int J Biol Macromol.
72:145–150. 2015. View Article : Google Scholar
|
|
19
|
Lin X, Yang Z, Zhang P and Shao G: miR-154
suppresses non-small cell lung cancer growth in vitro and in vivo.
Oncol Rep. 33:3053–3060. 2015.PubMed/NCBI
|
|
20
|
Xin C, Zhang H and Liu Z: miR-154
suppresses colorectal cancer cell growth and motility by targeting
TLR2. Mol Cell Biochem. 387:271–277. 2014. View Article : Google Scholar
|
|
21
|
Mian C, Pennelli G, Fassan M, Balistreri
M, Barollo S, Cavedon E, Galuppini F, Pizzi M, Vianello F, Pelizzo
MR, et al: MicroRNA profiles in familial and sporadic medullary
thyroid carcinoma: Preliminary relationships with RET status and
outcome. Thyroid. 22:890–896. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ren D, Minami Y and Nishita M: Critical
role of Wnt5a-Ror2 signaling in motility and invasiveness of
carcinoma cells following Snail-mediated epithelial-mesenchymal
transition. Genes Cells. 16:304–315. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yamagata K, Li X, Ikegaki S, Oneyama C,
Okada M, Nishita M and Minami Y: Dissection of Wnt5a-Ror2 signaling
leading to matrix metalloproteinase (MMP-13) expression. J Biol
Chem. 287:1588–1599. 2012. View Article : Google Scholar :
|
|
24
|
Nishita M, Enomoto M, Yamagata K and
Minami Y: Cell/tissue-tropic functions of Wnt5a signaling in normal
and cancer cells. Trends Cell Biol. 20:346–354. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
McDonald SL and Silver A: The opposing
roles of Wnt-5a in cancer. Br J Cancer. 101:209–214. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lu BJ, Wang YQ, Wei XJ, Rong LQ, Wei D,
Yan CM, Wang DJ and Sun JY: Expression of WNT-5a and ROR2
correlates with disease severity in osteosarcoma. Mol Med Rep.
5:1033–1036. 2012.PubMed/NCBI
|
|
27
|
Zhang A, He S, Sun X, Ding L, Bao X and
Wang N: Wnt5a promotes migration of human osteosarcoma cells by
triggering a phosphatidylinositol-3 kinase/Akt signals. Cancer Cell
Int. 14:152014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhao S, Ye X, Xiao L, Lian X, Feng Y, Li F
and Li L: miR-26a inhibits prostate cancer progression by
repression of Wnt5a. Tumour Biol. 35:9725–9733. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wei R, Deng Z and Su J: miR-217 targeting
Wnt5a in osteosarcoma functions as a potential tumor suppressor.
Biomed Pharmacother. 72:158–164. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Shan X, Miao Y, Fan R, Qian H, Chen P, Liu
H, Yan X, Li J and Zhou F: miR-590-5P inhibits growth of HepG2
cells via decrease of S100A10 expression and inhibition of the Wnt
pathway. Int J Mol Sci. 14:8556–8569. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Cai J, Guan H, Fang L, Yang Y, Zhu X, Yuan
J, Wu J and Li M: MicroRNA-374a activates Wnt/β-catenin signaling
to promote breast cancer metastasis. J Clin Invest. 123:566–579.
2013.PubMed/NCBI
|
